Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • TMUS vs MRNA✓SelectedUSD · MRNATMUS vs MRNA performance historyLatest closeAs of-2.31%11/18
Stock and ETF performance explorer

TMUS vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-21.4%
MRNA return
+703.6%
Excess return
-725.0%
Maximum drawdown
-33.1%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 1y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-2.3%-4.8%+2.5%-2.4%
7D-4.7%-20.9%+16.1%-5.1%
30D+5.1%-13.3%+18.3%+4.9%
3M-9.7%+212.6%-222.3%-7.6%
6M-13.0%+309.0%-322.0%-7.8%
YTD-17.9%+567.3%-585.2%-8.1%
1Y-21.4%+689.7%-711.1%-13.4%
All-21.4%+703.6%-725.0%-13.4%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 1y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

1y analysis · Full analysis span regression · 6 months rolling